Supplementary Figures 1-9, Table 1 from hsa-miR-191 Is a Candidate Oncogene Target for Hepatocellular Carcinoma TherapyEran Elyakim, Noga Yerushalmi, Alexander Faerman et al.|Unknown|2023Cited by 0